
FAMBILI in China – 2025: Strengthening Global Partnerships
We are grateful for the valuable meetings we had with our current and potential business partners during our 2025 visit to China! It was a great pleasure for us to explore collaboration opportunities in the global pharmaceutical sector and establish new connections.
As a leading pharmaceutical company based in Turkey, we are well aware that China is a global hub for technological innovations in healthcare and plays a pivotal role in shaping developments in this field. Thanks to the advanced technologies and modern solutions led by China, the future of the pharmaceutical industry is being shaped, and we are excited to be a part of this transformation at FAMBILI.
Our goal at FAMBILI is to combine Turkey’s strong pharmaceutical manufacturing legacy with the innovative power of technology-leading countries like China to provide high-quality healthcare solutions worldwide.
Our mission remains to deliver accessible, reliable, and innovative products to the global market.
We thank all our business partners in China with whom we had the opportunity to meet and discuss. We look forward to shaping the future of the healthcare sector together and continuing our strong collaborations!